Overview

Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency

Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This clinical research study will assess pharmacokinetics and the safety of Imrecoxib in patients with impaired hepatic function as compared to healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.